Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm

Leuk Lymphoma. 2020 Sep;61(9):2226-2229. doi: 10.1080/10428194.2020.1759052. Epub 2020 May 4.

¹ Service and Central Laboratory of Hematology, Oncology Department, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland.
² Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
³ Cell Factory and Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia.
⁴ Division of Hematology, Department of Oncology, University Hospital, Geneva, Switzerland.
⁵ Faculty of Medicine of Geneva, University of Geneva, Geneva, Switzerland.
⁶ Institute of Microbiology, University of Lausanne and University Hospital of Lausanne, Lausanne Switzerland.
⁷ Service of Immunology and Allergology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁸ Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland.
⁹ Department of Clinical Pathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
¹⁰ Department of Clinical Neurosciences, Service of Neurology, Neuroimmunology Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

No abstract available

Publication types